BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
PRKCA
,
Coagulation
,
Hepatitis
,
Retina
,
Laryngoscope
,
Valproic acid
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
n2 stage
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
MMP12
SCARA5
IL24
CA9
GRP
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
immune response
response to stress
DODD_NASOPHARYNGEAL_CARCINOMA_UP
regulation of immune system process
cytosol
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Clinical analysis of stage II-III breast cancer
Melanoma samples comparing nevi and primary and metastatic melanoma
Invasive breast carcinomas profiled based on histological and genomic grading
Colorectal tumor expression profiles
Hepatic metastases of colorectal cancer
Explore Curated Studies Results
Literature
Most Relevant Literature
Survival impact of unexpected N2 in stage IIIB/N2 non-small cell lung cancer patients.
Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung …
The First-Night Effect on the Instability of Stage N2: Evidence from the Activity of the Central and…
Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives].
Postoperative radiotherapy with modern techniques does not improve survival for operable stage IIIA-…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung …
NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation
Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation.
A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ